Arca Biopharma | ABIO - Current Liabilities


Arca Biopharma reported $20.97M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Amgen USD 25.49B 3.7B Dec/2025
Arca Biopharma USD 20.97M 8.86M Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Otsuka Holdings JPY 749.11B 50.84B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
United Therapeutics USD 560.6M 14.3M Dec/2025